Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK525495PMID: 30222287
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 298-57-7
Drug Levels and Effects
Summary of Use during Lactation
Cinnarizine is not approved for marketing in the United States by the U.S. Food and Drug Administration, but is available in other countries. No information is available on the use of cinnarizine during breastfeeding. Expert opinion recommends that cinnarizine not be used in migraine prophylaxis in nursing mothers.[1-3] An alternate drug is preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Migraine Prophylaxis) Divalproex, Erenumab, Metoprolol, Nortriptyline, Propranolol, Rimegepant, Topiramate, Valproic Acid
References
- 1.
- Pringsheim T, Davenport WJ, Mackie G, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(2) Suppl 2:S1–2. [PubMed: 22683887]
- 2.
- Negro A, Delaruelle Z, Ivanova TA, et al. Headache and pregnancy: A systematic review. J Headache Pain. 2017;18:106. [PMC free article: PMC5648730] [PubMed: 29052046]
- 3.
- Davanzo R, Bua J, Paloni G, et al. Breastfeeding and migraine drugs. Eur J Clin Pharmacol. 2014;70:1313–24. [PubMed: 25217187]
Substance Identification
Substance Name
Cinnarizine
CAS Registry Number
298-57-7
Drug Class
Breast Feeding
Milk, Human
Calcium Channel Blockers
Histamine H1 Antagonists
Vasodilator Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PMCPubMed Central citations
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Flunarizine.[Drugs and Lactation Database (...]Review Flunarizine.. Drugs and Lactation Database (LactMed®). 2006
- Review Prazosin.[Drugs and Lactation Database (...]Review Prazosin.. Drugs and Lactation Database (LactMed®). 2006
- Review Cyclizine.[Drugs and Lactation Database (...]Review Cyclizine.. Drugs and Lactation Database (LactMed®). 2006
- Review Tranylcypromine.[Drugs and Lactation Database (...]Review Tranylcypromine.. Drugs and Lactation Database (LactMed®). 2006
- Review Dantrolene.[Drugs and Lactation Database (...]Review Dantrolene.. Drugs and Lactation Database (LactMed®). 2006
- Cinnarizine - Drugs and Lactation Database (LactMed®)Cinnarizine - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...